Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 10021–10040 of 17,529 recalls

July 14, 2017· SCA Pharmaceuticals

Recalled Item: ePHEDrine Sulfate 5 mg/mL in NS 5 mL Fill in 12 mL Syringe (25 mg)

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL as citrate 5 mcg/mL in 0.9% Sodium Chloride 1 mL in Single Dose syringe

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine 10 mg in 0.9% Sodium Chloride 250 mL bag

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: BUPIVacaine HCl 0.2% IN 0.9% Sodium Chloride 250 mL Bag

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: NORepinephrine 4 mg in 0.9% Sodium Chloride 250 mL from Stock

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: BUPIVacaine HCl 0.1% PF (From 0.75%) in 0.9% Sodium Chloride

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: Potassium Chloride 20 meq Added to Sodium Chloride 0.9% 250 mL

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: NORepinephrine Bitartrate 16 mg in 0.9% Sodium Chloride 250 mL from Stock

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine HCl 25 mg in 0.9% Sodium Chloride 250 mL

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine 100 mg in 0.9% Sodium Chloride 250 mL Bag

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL 3 mcg/mL + BUPIvacaine 0.1% in 0.9% Sodium Chloride 250 mL

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: EPINEPHrine HCl 4 mg in 0.9% Sodium Chloride 250 mL

The Issue: Lack of Assurance of Sterility; product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine HCl 10 mg in 0.9% Sodium Chloride

The Issue: Lack of Assurance of Sterility: Product made with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 12, 2017· Pfizer Inc.

Recalled Item: Deferoxamine Mesylate for injection

The Issue: CGMP Deviations: Firm failed to control impurity for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 12, 2017· Akorn Inc

Recalled Item: Halyard 24-Hour Oral Care Kit q2

The Issue: Crystallization with subpotent out of specification assay results

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 12, 2017· Akorn Inc

Recalled Item: Chlorhexidine Gluconate Oral Rinse

The Issue: Crystallization with subpotent out of specification assay results

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 12, 2017· Akorn Inc

Recalled Item: Halyard 24-Hour Oral Care Kit q4

The Issue: Crystallization with subpotent out of specification assay results

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 12, 2017· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Testosterone Cypionate + Progesterone

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 11, 2017· Dr. Reddy's Laboratories, Inc.

Recalled Item: Pravastatin Sodium Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 6, 2017· Hospira Inc., A Pfizer Company

Recalled Item: Argatroban Injection

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund